ResApp Health Limited (RAP) is a digital health company developing smartphone applications for the diagnosis and management of respiratory disease. The technology is based on machine learning algorithms that use cough sounds to diagnose and measure the severity of respiratory conditions without the need for additional hardware. On 23 August 2019, the Company announced that its first commercial product, ResAppDx-EU, has received CE Mark certification as a Class IIa medical device.
ResApp Health Limited operators in Health Care sector and under industry of Health Care Technology. The company website is: http://www.resapphealth.com.au.
You can also check out dividend history for similar stocks in the same sector as follows:
RAP Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found